-
Recent Posts
- Pre-Owned Vehicle Marketing – Stellantis, Cox Automotive
- Chinese Junk Watch Death Risk – Luyuan Youth ATVs
- ICE Vehicle Mobile Apps – Wide Satisfaction Differences
- Sports Betting Tax Revenues Soaring
- IndyCar Cheating – New Independent Officiating for 2026 Series
- Ford Expands Mustang Cup USA Series in 2026
- GM Canada Leadership Change – Jack Uppal new President
- Toyota Enhances Arizona Proving Ground
- Happy Nightmare! Holiday Travel to Set New Record
- First Look – $34,995 Subaru Uncharted EV
- Stellantis and Bolt Partner on Driverless Mobility
- Detroit Auto Show – Official U.S. Route 66 Centennial Project
- Genesis Recall for Sudden Unintended Braking
- Road Hazard – Ford Escape Liftgate Hinge Cover Recall
- Lando Norris Wins Formula One World Drivers’ Championship
Recent Comments
- Magna on its Share Repurchase Plan in reference to on Magna Posts Solid Q3 2025 Earnings Gain
- Daniel Ricciardo Global Ford Racing Ambassador on Ford Performance Rebranded as Ford Racing
- Gen 3 2026 Nissan Leaf Less than $30,000? | AutoInformed on Milestones – Nissan Begins Assembly of 2013 LEAF EV in Tennessee
- ACSI – Customer Satisfaction with Autos Dropping | AutoInformed on New DOGE Scorecard Announced to Track Trump
- Cadillac Off-Roader – Elevated Velocity | AutoInformed on Annals of Marketing – Cadillac Opulent Velocity Concept EV
Archives
Meta
Get intelligent commentary on the automobile business and its economic and social effects. Stay informed with AutoInformed.
Commerce, HHS, FDA to Fight Online Opioid Sales
The Department of Commerce and the Department of Health and Human Services (HHS) today revealed a 120-day pilot program to curb illegal online sales of unapproved opioids.
Under the program, the National Telecommunications and Information Administration (NTIA) and the U.S. Food and Drug Administration (FDA) will work with three domain name registries, Neustar (.us), Verisign (.com, .net) and Public Interest Registry (.org), to suspend the domain names of websites found to be illegally selling unapproved opioids.
The FDA will serve as a “trusted notifier” to alert the registries about websites that are illegally selling unapproved opioids. Upon receiving notice from the FDA, a registry may then voluntarily lock the domain, delete the domain, or place the domain on hold, as appropriate. The “trusted notifier” designation expedites the process for suspending domain name registrations.
About Ken Zino
Ken Zino, editor and publisher of AutoInformed, is a versatile auto industry participant with global experience spanning decades in print and broadcast journalism, as well as social media. He has automobile testing, marketing, public relations and communications experience. He is past president of The International Motor Press Assn, the Detroit Press Club, founding member and first President of the Automotive Press Assn. He is a member of APA, IMPA and the Midwest Automotive Press Assn. He also brings an historical perspective while citing their contemporary relevance of the work of legendary auto writers such as Ken Purdy, Jim Dunne or Jerry Flint, or writers such as Red Smith, Mark Twain, Thomas Jefferson – all to bring perspective to a chaotic automotive universe. Above all, decades after he first drove a car, Zino still revels in the sound of the exhaust as the throttle is blipped during a downshift and the driver’s rush that occurs when the entry, apex and exit points of a turn are smoothly and swiftly crossed. It’s the beginning of a perfect lap. AutoInformed has an editorial philosophy that loves transportation machines of all kinds while promoting critical thinking about the future use of cars and trucks. Zino builds AutoInformed from his background in automotive journalism starting at Hearst Publishing in New York City on Motor and MotorTech Magazines and car testing where he reviewed hundreds of vehicles in his decade-long stint as the Detroit Bureau Chief of Road & Track magazine. Zino has also worked in Europe, and Asia – now the largest automotive market in the world with China at its center.